U.S. FDA loosens alcohol restrictions for female libido pill
(Reuters) – The U.S. Food and Drug Administration said on Thursday women taking Sprout Pharmaceuticals Inc’s female libido pill, Addyi, need not completely avoid alcohol.
The FDA ordered Sprout to make changes to the drug’s label to reflect that patients should stop drinking two hours before taking Addyi at bedtime or to skip the dose that evening.
Approved by the FDA in August 2015, Addyi is meant to be taken daily.
The drug carries a boxed warning, FDA’s strictest, about potentially dangerous low blood pressure and fainting, especially when taken with alcohol. Patients taking the…